Category: Asean

The Apollo4 Lite and Apollo4 Blue Lite System-on-Chips (SoCs) Help Enhance Devices’ Functionalities and Battery Life to Accelerate the Adoption of Remote Monitoring

News Highlights:

• The new Apollo4 Lite and Blue Lite SoCs offer feature-rich capability, optimized memory, powerful graphics performance, and secureSPOT^® for robust security in a lightweight solution
• Ideal for digital health applications, such as digital stethoscopes, patient monitoring, and continuous glucose and blood pressure monitoring
• The Apollo4 Blue Lite offers secure Bluetooth^® Low Energy connectivity for communication to handheld devices, host equipment, and the Cloud

AUSTIN, Texas, July 10, 2023 (GLOBE NEWSWIRE) — Ambiq^®, a technology leader in ultra-low power semiconductor products and solutions, introduces the Apollo4 Lite and Apollo4 Blue Lite SoC to its expanding portfolio of SoCs for IoT endpoint devices, especially the remote monitoring products of the healthcare sector. This announcement follows Ambiq’s release of its Heart Kit, an optimized open-source AI model utilizing multi-head neural networks (MH-NNs) to enable a variety of real-time heart-monitoring applications.

The Apollo4 Lite and Blue Lite product line is the latest generation system processor solutions built upon Ambiq’s proprietary Subthreshold Power-Optimized Technology (SPOT^®) platform, enabling new features while reducing devices’ overall system power consumption to extend their battery life. Both SoCs are embedded with an ultra-low power Cortex-M4 core that can operate at up to 192 MHz with turboSPOT, an audio subsystem, GPU, and ample MRAM and SRAM. They are also conveniently pin-compatible with Ambiq’s Apollo4 Plus and Blue Plus¹, providing developers with optimum flexibility for innovation.

“Today’s patients are more empowered to monitor and advocate for their own health, and healthcare providers require more data analytics to prescribe holistic treatment,” said David Priscak, VP of Technical Solutions at Ambiq. “With bold graphics and long battery life, state-of-the-art health tracking is now more affordable and accessible thanks to these new additions to our Apollo4 SoC family.”

Apollo4 Lite / Blue Lite Chart

“The global remote patient market in terms of revenue was estimated to be worth $53.6 billion in 2022 and is poised to reach $175.2 billion by 2027, growing at a CAGR of 26.7% from 2022 to 2027,” said Ms. Anu Dhiman – Lead Healthcare Analyst – MarketsandMarkets Research Pvt. Ltd. “The predominant factors influencing the growth of the market include the benefits of remote patient monitoring to reduce the burden on medical resources, the monitoring benefits of telehealth and remote patient monitoring services, advancements in telecommunications, as increasing geriatric population, and the growing need to expand healthcare access.”

The Apollo4 Lite and the Apollo4 Blue Lite are designed for extended battery life, advanced security, and powerful graphics in small form factors, which are critical for the continued adoption of these devices. Both are now in mass production, targeting digital health products, smartwatches, fitness bands, animal trackers, voice-activated remotes, industrial maintenance, and smart home IoT devices. For more product information, visit www.ambiq.com/apollo4-lite and www.ambiq.com/apollo4-blue-lite.

¹ – Apollo4 Lite is pin-compatible with Apollo4 Plus (AMAP42KP-KBR); Apollo4 Blue Lite is pin-compatible with Apollo4 Blue Plus (AMA4B2KP-KXR.)

About Ambiq

Ambiq’s mission is to develop the lowest-power semiconductor solutions to enable intelligent devices everywhere by developing the lowest-power semiconductor solutions to drive a more energy-efficient, sustainable, and data-driven world. Ambiq has helped leading manufacturers worldwide develop products that last weeks on a single charge (rather than days) while delivering a maximum feature set in compact industrial designs. Ambiq’s goal is to take Artificial Intelligence (AI) where it has never gone before in mobile and portable devices, using Ambiq’s advanced ultra-low power system on chip (SoC) solutions. Ambiq has shipped more than 200 million units as of March 2023. For more information, visit www.ambiq.com.

Contact

Charlene Wan
VP of Branding, Marketing, and Investor Relations
cwan@ambiq.com
+1.512.879.2850

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/620a2f10-acfe-4d54-b9c3-0983c58c06f6

https://www.globenewswire.com/NewsRoom/AttachmentNg/fd179ebf-2f60-4195-8fca-b88c7b7a852c

GlobeNewswire Distribution ID 8870834

Quantexa CEO outlines vision for investment in support of UK Government’s plan to make UK an AI Hub, which includes:

• £125M in new global investments aimed at accelerating enterprise and government agency’s ability to use trusted AI-enabled Decision Intelligence solutions
• £85M in dedicated UK investment will create over 170 new jobs in London AI Innovation Centre team
• Preview of Generative AI assistant shows how world-leading institutions will unlock the full potential of data to investigate risk and identify opportunity

LONDON and NEW YORK, July 09, 2023 (GLOBE NEWSWIRE) — Quantexa, a global leader in Decision Intelligence (DI) solutions for the public and private sectors, announced today that it will invest an additional £125M in the global artificial intelligence (AI) industry over the next three years to help clients advance the use of AI to protect, optimise, and grow their organisations. By 2027, Quantexa’s total global investment in AI will reach more than £200M.

The investment marks Quantexa’s continued advancements in AI with the preview of its Generative AI technology, Q Assist. Quantexa also furthered its commitment to advancing the company’s existing AI Stack to enable its growing global ecosystem of clients and partners to unlock new industry-specific use cases for financial services, insurance, telecommunications, healthcare, and in the public sector. Quantexa’s Decision Intelligence platform and suite of solutions for data management, customer intelligence, KYC, risk, fraud, and financial crime have been deployed in over 70 countries.

Analysis from University of Washington suggests this investment will boost the global AI industry by £600M as the multiplier effect is realised.

AI in Context: How Quantexa Augments and Automates Decision Intelligence with AI

Preview of Generative AI Assistant Breaks New Ground
Built on Quantexa’s Decision Intelligence Platform, the technology preview of Q Assist, a generative AI assistant, demonstrates the potential of using LLM’s to create an intuitive and conversational interface bringing new efficiencies for analysts working with data to identify risks as part of investigations. For organisations, the potential benefit is significant – as the AI assistant allows all analyst staff to become as effective as the most experienced investigators.

Q Assist is LLM agnostic and will allow clients to use their own proprietary, open source, or commercially available models including ChatGPT^TM, a leading LLM from OpenAI. Quantexa’s market-leading entity resolution, graph analytics, and scoring capabilities become turbo-charged when they can be queried with natural language questions and prompts in Quantexa’s Decision Intelligence Platform.

Today, in a video showcase, Quantexa demonstrated one of what could become many potential use cases for Q Assist. The financial crime investigation scenario was chosen to show the potential in using natural language to query vast amounts of structured and unstructured data at scale, allowing even junior analysts to understand the complex data behind graph analytics and alerts. The preview also showed the ability to automate the generation of Suspicious Activity Reports (SARs) and investigative summaries – possible in close to 100 languages – driving further efficiency in what is typically a manually intensive process and allowing more time to be redirected to strategic activities.

AI Throughout Quantexa’s Decision Intelligence Platform Delivers Business Value
Enterprises and government agencies are using Quantexa’s Decision Intelligence to become more effective and efficient at organising siloed, messy data to obtain 360-degree views of customers and suppliers to identify fraud, qualify eligibility for services, stop dangerous goods at borders, or optimise supply chains.

Quantexa is using three core principles to responsibly build out its AI Stack:

• Context-Based Learning: Just as humans require full context to make informed decisions, so does AI. Without context, even the smartest machine learning or deep learning algorithms lack accuracy to be deployed reliably. For example, it’s impossible for a person or AI model to know if a single bank transaction in isolation is money laundering. Quantexa builds true context by using data to create single views of people, organisations, places, and other entities and assembles them visually to show complex interactions between entities. This context is what enables a person or AI to make an accurate decision.
• Composite AI: Quantexa’s Composite AI Stack aggregates the outputs of many different techniques, including machine learning, natural language processing and deep learning. Combining these with input from subject matter experts, organisations can continually use analytics to improve decisioning to protect, optimise, and grow. Quantexa uses exclusive access to huge volumes of structured and unstructured industry data to train its AI and provides out-of-the-box open models, giving clients the ability to modify or create their own.
• Explainability and Trust: In the highly regulated environments that organisations work in, it is crucial that decisions are transparent and explainable with no suggestion of bias. Quantexa’s technology and governance uses context-based techniques and composite AI to drive adoption of explainable outcomes without privacy concerns. Quantexa publicly maintains its AI ethics and safety guidelines here.

Rishi Sunak, Prime Minister of the United Kingdom, said:
“We want to ensure the UK remains the best place in the world to build, test, and use safe AI technology. Quantexa’s new £85M London AI Innovation Centre will help cement this reality. It will create over 170 jobs, harness the extraordinary potential of AI as we grow our economy, and lead the way on responsible AI development around the world.”

Chloe Smith, Technology Secretary, said:
“The Government is serious about AI, which is why we’ve invested £2.5B in AI infrastructure and skills since 2014 and this year set out our plan for AI regulation to drive innovation and build trust. Quantexa’s investment is a huge vote of confidence in those plans and will unlock new opportunities for growth and job creation, enabling us to continue to pave the way as a global leader in the development of AI.”

Vishal Marria, CEO and Founder, Quantexa, said:
“While many companies are talking about AI and machine learning, we have been investing in it since our inception. We are investing our time, money, and resources into the biggest technological breakthrough for generations as it will transform how organizations make decisions. We’re proud to invest in London-based innovation but the impact will be felt by the global economy and will start a ripple effect that will unlock decision intelligence capabilities for our clients and their respective industries.” 

Dr Oren Etzioni, Professor at the University of Washington’s Computer Science and founding CEO of the Allen Institute for AI, said: “An investment of 100 AI jobs will drive economic growth not just in London but around the world. The places most likely to benefit are AI innovation hubs like New York City, Seattle, and San Francisco. Based on my research into the impact of AI on employment and economic growth, the long-term monetary benefits of this announcement will increase significantly because of the multiplier effect from job creation and innovation. An initial investment of £200M is likely to benefit the wider AI industry by £600M globally within three years.” 

To learn more about how your organisation can benefit from Quantexa’s AI investment, innovation, and ethical practices, please visit here.

About Quantexa
Quantexa is a global data and analytics software company pioneering Decision Intelligence that empowers organisations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa’s Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, KYC, customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90% more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 650 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, New York, Boston, Toronto, Malaga, Brussels, Amsterdam, Ireland, Luxemburg, Singapore, Melbourne, Sydney, and the UAE. For more information, please visit www.quantexa.com or follow us on LinkedIn.

Media Enquiries
C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight
E: Quantexa@fightflight.co.uk

C: Adam Jaffe, SVP of Corporate Marketing
T: +1 609 502 6889
E: adamjaffe@quantexa.com
– or –
RapidResponse@quantexa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/afbbd220-e3ee-4c36-b53e-3f10d3634414

GlobeNewswire Distribution ID 1000829195

Tsui to touch on the company’s future ambitions & strategic road map including supply chain circularity and the portal’s AI capabilities

NEW YORK and HONG KONG, July 05, 2023 (GLOBE NEWSWIRE) — Floship, a leading global circular supply chain solutions provider, today announced its participation in The Lead Innovation Summit, a leading strategy conference for global decision-makers and executives in today’s retail and consumer industries. The conference takes place in New York City between 12 & 13 July.

Floship CEO Josh Tsui will deliver his Vision Talk on Wednesday, 12 July during the session “Optimizing Digital Commerce Opportunity” fielding questions from Dawit Heck of Bain Capital Ventures. Tsui will share information about Floship, his strategic vision, as well as the company’s transformational ambitions including his thoughts on the future of generative AI in e-commerce to an audience of 2000+ executives from major global brand retailers.

As part of his talk, Tsui will share information about Floship’s holistic circular supply chain ecosystem, illustrating how it connects every core component across the value chain from the manufacturer, warehouse systems, delivery mechanisms, and returns solutions through a wholly integrated platform.

Also at The Summit, Floship will be among the companies recognized on The Lead’s Leading 100 List in an award ceremony, which honors innovative tech start-ups that are driving the future of brand-to-consumer businesses, especially in helping these businesses adopt circular supply chains.

“It is an extremely exciting time here at Floship, and I’m honored that we’re being acknowledged for our disruptive innovations toward the business-to-consumer model. Supply chain circularity and generative AI are extremely important supply chain focus areas for merchants as they work hand-in-hand to minimize the use of raw materials, reduce excessive amounts of discarded waste materials, and automate many manually intensive processes,” said Tsui. “We believe the Lead Innovation Summit provides the necessary backdrop to continue to tell this story to an audience who are cognizant of the need to build more sustainable and intelligent supply chains by leveraging technologies that empower consumers, businesses, and the economy to be more efficient with a leaner amount of resources.”

Circular supply chains involve a company reusing or repurposing waste and customer returns to convert those resources into new or refurbished products, and this strategy is critical in building global partnerships. Floship recently announced one such partnership with FedEx that is designed to provide enhanced fulfillment and logistics services to e-tailers worldwide. The partnership gives FedEx’s e-commerce customers access to Floship’s global network of warehouses and powerful logistics platform’s capabilities to streamline their e-commerce fulfillment operations. At the same time, Floship’s customers will be able to leverage FedEx global networks as well as a full range of FedEx extensive transportation options to optimize their operations.

The Lead Innovation Summit is where 2,000+ leaders from the fashion, beauty, home, consumer & retail innovation communities converge to learn from and connect with scaled brands, digital natives, & technology enablers. The two-day summit features more than 140 stand-out speakers and 45 content sessions and breaks down every aspect of a brand’s direct-to-consumer business, online and offline.

About Floship
Floship’s global circular supply chain ecosystem solutions cover all aspects of the global supply chain, ensuring minimal operation effort for e-commerce businesses while exceeding their expectations, allowing business owners to concentrate on driving growth and investment flexibility while gaining peace of mind. Learn more at www.floship.com or follow us on LinkedIn.

E info@floship.com   W www.floship.com
Level 7, 18 Salisbury Rd, Tsim Sha Tsui, Hong Kong
香港尖沙咀梳士巴利道18號7樓

For more information about Floship, please contact:

James Linacre, PR & Communications Lead

Phone: (+852) 5333 9420

Email: james@floship.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6e85ddb6-bd4c-4a24-9422-a4429f79a882

GlobeNewswire Distribution ID 8868173

LONDON and BANGKOK, Thailand, July 03, 2023 (GLOBE NEWSWIRE) — Aztiq Pharma Partners (“Aztiq”), a private equity company focused on the life sciences sector, and Innobic (Asia) Company Limited (“Innobic”), the life science arm of Thai oil and gas conglomerate PTT Public Company Limited (“PTT”) (collectively, “the shareholders”), today announced the pricing of a sale of 25,095,850 shares of Lotus Pharmaceuticals (1795:TT; “Lotus,” “the company”), a multinational pharmaceutical company, at a price of NT$297 per share. The trade will be settled on July 5, 2023, subject to satisfaction of customary settlement procedures. The sale is being executed by Alvogen Emerging Market Holdings Limited (“AEMH”), which will continue to own 41% of Lotus common stock after the close of the transaction. Inclusive of Innobic’s direct holdings of Lotus, the shareholders will continue to own approximately 47.7% of the company.

Robert Wessman, Founder of Aztiq, commented: “Today’s announcement is a big step in the evolution of Lotus that started as a company whose business was nearly entirely domestic. The company today has evolved into a global pharmaceutical company with a vast portfolio of products and a global reach that touches nearly every corner of the world through the company’s export business or through Lotus’s own commercial infrastructure that spreads throughout Asia. As Chairman, I look forward to continuing to work with Lotus’ proven management team that has led this transformation to collaborate on strategy and grow the business going forward.”

Dr. Buranin Rattanasombat, Chief New Business and Infrastructure Officer of PTT, and Chairman of Innobic, commented: “This transaction is a significant step for Lotus as it concurrently increases free-float of the stock and diversifies the shareholder base with strong institutional investors. As a leading shareholder of Lotus, our interests remain truly aligned with those of the company and its valued shareholders.”

J.P. Morgan and Credit Suisse are acting as placing agents for the trade.

About Aztiq

Aztiq is a visionary healthcare focused private equity company dedicated to fostering innovation and driving positive change within the industry. Led by Robert Wessman and a team of veteran entrepreneurs, Aztiq is committed to identifying, investing in, and nurturing ground-breaking healthcare solutions in pharma and biotech to address global healthcare challenges. By leveraging the cumulative experience of the team, Aztiq aims to improve patient outcomes, increase access to quality healthcare, and create a more efficient and sustainable healthcare ecosystem. With a proven track record of success, Aztiq continues to make a lasting impact on the health and well-being of people around the world. For more information, please visit www.aztiq.com and follow Aztiq on LinkedIn.

About Innobic

Innobic (Asia) Company Limited is a wholly-owned subsidiary of PTT, the largest energy company in Thailand majority owned by Ministry of Finance Thailand and listed in Fortune Global 500. PTT has moved from a national energy provider to a multinational conglomerate and started to diversify the business into new sectors, including Life Science, Renewables, Electricity value chain, and Ventures, to serve as its new S-curve. It officially established Innobic in December 2020 for a strategic goal to building up a new footprint in Life Science fields for PTT Group, with an initial focus on pharmaceuticals, and aims to make Innobic become a leading Life Science company in the region to bring best science and enhance life qualify of people. For more information, please visit www.innobicasia.com

Media Enquiries:

Ming Li
+16465093032
ming.li@aztiq.com

Jaruchai Sutjarittam
+66888924564
Jaruchai.s@innobicasia.com

GlobeNewswire Distribution ID 1000828093

Verifone T650m Mobile Payment Device

Verifone M440 Multilane Payment Device

Basseterre, June 29, 2023 (GLOBE NEWSWIRE) — International investors have been clamouring to take advantage of one of the best deals in the investment migration industry this year – St Kitts and Nevis’ Sustainable Growth Fund (SGF) Limited Time Offer (LTO) which allows investors to gain approval for alternative citizenship in the country in as little as 60 days for a reduced fee.

In December 2022, the St Kitts and Nevis Head of the Citizenship by Investment Unit (CIU), Michael Martin, announced the enactment of the updated St Kitts and Nevis Citizenship by Investment Regulations 2023, which included the introduction of the LTO for the SGF investment option effective 1 January 2023 – 30 June 2023.

On 29 June 2023, Michael Martin made the following comment regarding the LTO:

“We have received an overwhelming response and demand for our Sustainable Growth Fund investment option through the Limited Time Offer and felt that we had to extend the offering for another seven months until 31 January 2024. International investors continue to see the value of the world’s first and finest Citizenship by Investment Programme and this proves it”.

The SGF remains the quickest and easiest route to alternative citizenship in St Kitts and Nevis and now until 31 January 2024, a main applicant can acquire alternative citizenship by contributing only US$125,000 to the SGF and receiving approval in principle within 60 days of acknowledgement by the CIU of submission of their application.

Under the LTO, the minimum SGF contributions are as follows:

• Single applicant – US$ 125,000
• Main applicant and a spouse – US$150,000

• Main applicant and up to three dependants – US$170,000
• Each additional dependant under 18 – US$10,000
• Each additional dependant over 18 – US$25,000

Revenue from the SGF has facilitated economic development and social upliftment in the country. The SGF is used to provide financial support to educational institutions, and medical facilities, as well as support infrastructural development, increase tourism, preserve local culture and heritage and support sustainable growth initiatives in the twin-island nation.

Discerning investors are seeing the benefits of being part of St Kitts and Nevis’ success story. Following upgrades to the CBI Regulations, the country now offers one of the most secure and best-regulated investment migration offerings in the world.

This means that international investors looking to hedge their bets in a stable and growing economy should look no further than St Kitts and Nevis.

This extension is a fantastic opportunity for investors to obtain citizenship through the LTO. This is a final extension and from 1 February 2024, the minimum SGF contribution will increase to the amounts prior to the LTO period.

The country is making sure that it has only the best to offer international entrepreneurs and families who have realised that global powerhouses are no longer illustrious investment options due to security risks. Investors want to ensure that they can safeguard their families and wealth in a global economy that has been offering nothing but uncertainty since the onset of the COVID-19 pandemic in 2020.

Smaller governments such as that of St Kitts and Nevis have found ways, through CBI, to protect themselves from global shocks, offer favourable business policies aimed at growing corporations in international markets and, by using international funds channelled to the SGF, can diversify and grow their economy to meet global needs.

St Kitts and Nevis continues to create a name for itself as a financial nexus in the Caribbean with an attractive CBI programme underpinned by a sound legal framework and robust multi-layered due diligence.

For nearly 40 years, St Kitts and Nevis has been the pioneer of the global investor immigration industry and those who recognise this are taking advantage of the LTO.

St Kitts and Nevis continues to create a name for itself as a financial nexus in the Caribbean with an attractive CBI programme underpinned by a sound legal framework and robust multi-layered due diligence.

For nearly 40 years, St Kitts and Nevis has been the pioneer of the global investor immigration industry and those who recognise this are taking advantage of the LTO.

Chantal Mabanga
Government of St. Kitts and Nevis
+44 (0) 207 318 4343
chantal.mabanga@csglobalpartners.com

GlobeNewswire Distribution ID 8867177

Curia recognized for providing a best-in-class customer experience in the CRDMO industry through its innovative approach and growth strategy

ALBANY, N.Y., June 29, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a Best Practices Customer Value Leadership Award in the CRDMO industry by Frost & Sullivan.

“We are very honored to be recognized with this award, which underlines the hard work and dedication of all of our employees to delivering quality and reliability when serving our customers,” said Philip Macnabb, CEO, Curia. “We remain steadfast in our noble purpose of improving patients’ lives, a mission that begins with our commitment to creating value for our customers.”

Frost & Sullivan noted in its report that the company’s rebrand from AMRI to Curia in 2021 put a focus on science at the center of its brand identity, highlighting a pledge to help customers advance “from curiosity to cure.” Curia has evolved over time to offer a comprehensive range of services from drug discovery through development to manufacture of both drug substance and drug product for pharmaceutical and biologics companies. The award recognizes how Curia seeks out innovative solutions by using the latest technologies to efficiently move products from discovery to development to commercial scale to accelerate speed to market for its customers. This continuous commitment to serve unspoken market needs and deliver end-to-end solutions for customers has positioned it as an industry leader.

“Curia has built its reputation by offering a best-in-class customer ownership and service experience. The company surveys clients to gauge their overall satisfaction and ensure that it is upholding the highest standards,” said Unmesh Lal, director, Healthcare & Life Sciences, Frost & Sullivan.

Each year, Frost & Sullivan employs a rigorous evaluation, measuring business and customer impact, to identify companies that consistently innovate to meet their customers’ needs while navigating new challenges and opportunities. The winner is recognized for providing a superior customer experience for overall price, performance and quality.

About Curia
Curia, formerly AMRI, is a leading contract research, development, and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s nearly 4,000 employees at 29 locations across the U.S., Europe, and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.

About Frost & Sullivan
Frost & Sullivan is the Growth Pipeline Company. We power our clients to a future shaped by growth. Our Growth Pipeline as a Service provides the CEO and the CEO’s growth team with a continuous and rigorous platform of growth opportunities, ensuring long-term success. To achieve positive outcomes, our team leverages over 60 years of experience, coaching organizations of all types and sizes across 6 continents with our proven best practices. To power your Growth Pipeline future, visit Frost & Sullivan at http://www.frost.com.

Curia Contact Information:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8865503